Exagen Diagnostics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Exagen Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012885
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exagen Diagnostics Inc (Exagen) is a medical device company that offers diagnostic tools. The company provides clinical tools for diagnosis, monitoring and prognosis of autoimmune connective tissue disease. Its products are used for therapeutic drug monitoring of hydroxychloroquine in whole blood and methotrexate polyglutamates, risk assessment testing, anti-TNF monitoring to individualize therapy and optimize dosing, and others. Exagen offers avise ctd, avise sle prognostic, avise infliximab and avise adalimumab, avise hcq, and avise mtx. The company serves physicians and patients. It operates in Vista and Albuquerque, the US. Exagen is headquartered in Vista, California, the US.

Exagen Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exagen Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exagen Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exagen Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Exagen Diagnostics Raises USD1.3 Million in Venture Financing 10
Exagen Diagnostics Raises USD1.5 Million in Venture Financing 11
Exagen Diagnostics Raises USD1 Million in Venture Financing 12
Exagen Diagnostics Raises USD1 Million in Venture Financing 13
Exagen Diagnostics Raises USD1 Million in Venture Financing 14
Exagen Diagnostics Raises USD1 Million in Venture Financing 15
Exagen Diagnostics Raises USD1 Million in Venture Financing 16
Exagen Diagnostics Raises USD1 Million in venture financing 17
Exagen Diagnostics Raises USD2 Million in Venture Financing 18
Exagen Diagnostics Raises USD16.81 Million in Venture Financing 19
Exagen Diagnostics Raises USD3 Million in Venture Financing 20
Exagen Diagnostics Raises USD2 Million in Venture Financing 21
Exagen Diagnostics Raises USD4 Million in Venture Financing 22
Exagen Diagnostics Raises US$5 Million In Venture Financing 23
Exagen Diagnostics Raises US$0.12 Million In Venture Financing 24
Exagen Raises US$5.3 Million In Venture Financing 25
Exagen Diagnostics Secures US$12 Million In Series D Venture Financing 26
Exagen Diagnostics Secures Additional US$3.4 Million In Financing Round 27
Exagen Diagnostics Inc – Key Competitors 28
Exagen Diagnostics Inc – Key Employees 29
Exagen Diagnostics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Product News 31
Oct 31, 2017: Exagen Diagnostics Featured in Five Scientific Posters at 2017 ACR/ARHP Annual Meeting in San Diego 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Exagen Diagnostics Inc, Medical Equipment, Key Facts 2
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exagen Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exagen Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exagen Diagnostics Raises USD1.3 Million in Venture Financing 10
Exagen Diagnostics Raises USD1.5 Million in Venture Financing 11
Exagen Diagnostics Raises USD1 Million in Venture Financing 12
Exagen Diagnostics Raises USD1 Million in Venture Financing 13
Exagen Diagnostics Raises USD1 Million in Venture Financing 14
Exagen Diagnostics Raises USD1 Million in Venture Financing 15
Exagen Diagnostics Raises USD1 Million in Venture Financing 16
Exagen Diagnostics Raises USD1 Million in venture financing 17
Exagen Diagnostics Raises USD2 Million in Venture Financing 18
Exagen Diagnostics Raises USD16.81 Million in Venture Financing 19
Exagen Diagnostics Raises USD3 Million in Venture Financing 20
Exagen Diagnostics Raises USD2 Million in Venture Financing 21
Exagen Diagnostics Raises USD4 Million in Venture Financing 22
Exagen Diagnostics Raises US$5 Million In Venture Financing 23
Exagen Diagnostics Raises US$0.12 Million In Venture Financing 24
Exagen Raises US$5.3 Million In Venture Financing 25
Exagen Diagnostics Secures US$12 Million In Series D Venture Financing 26
Exagen Diagnostics Secures Additional US$3.4 Million In Financing Round 27
Exagen Diagnostics Inc, Key Competitors 28
Exagen Diagnostics Inc, Key Employees 29
Exagen Diagnostics Inc, Other Locations 30

★海外企業調査レポート[Exagen Diagnostics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Navamedic ASA (NAVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Interpace Diagnostics Group Inc (IDXG)-製薬・医療分野:企業M&A・提携分析
    Summary Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform; a …
  • Kura Oncology Inc (KURA)-製薬・医療分野:企業M&A・提携分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company which discovers and develops therapeutics for the treatment of solid tumors and blood cancers. Its lead drug candidate, Tipifarnib, an inhibitor of protein farnesylation, is a small molecule that targets oncogene …
  • Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析
    Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Grainger Plc (GRI):企業の財務・戦略的SWOT分析
    Grainger Plc (GRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • EWE AG:石油・ガス:M&Aディール及び事業提携情報
    Summary EWE AG (EWE) operates in energy, telecommunication and information technology businesses. The company is involved in generation and transmission of energy, gas storage and waste water treatment. EWE plans, builds and operates renewable power generation plants globally. The company operates c …
  • Procurri Corporation Limited (BVQ):企業の財務・戦略的SWOT分析
    Procurri Corporation Limited (BVQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Olympus Corporation (7733)-医療機器分野:企業M&A・提携分析
    Summary Olympus Corporation (Olympus) is a manufacturer of precision machineries and instruments. The company develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers a wide range of products including digital SLR …
  • Tanzania Electric Supply Co Ltd:発電所・企業SWOT分析
    Tanzania Electric Supply Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Transgene SA (TNG):企業の財務・戦略的SWOT分析
    Summary Transgene SA (Transgene) a subsidiary of Institut Merieux SA operates as a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develop …
  • Saladax Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, M …
  • Royal Mail plc:企業の戦略・SWOT・財務分析
    Royal Mail plc - Strategy, SWOT and Corporate Finance Report Summary Royal Mail plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Autoliv, Inc.:企業の戦略・SWOT・財務分析
    Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Omeros Corp (OMER):企業の財務・戦略的SWOT分析
    Omeros Corp (OMER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • S-Oil Corporation Inc (010950):企業の財務・戦略的SWOT分析
    S-Oil Corporation Inc (010950) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Cocoon Holdings Ltd (428):企業の財務・戦略的SWOT分析
    Cocoon Holdings Ltd (428) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • IMPACT Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary IMPACT Therapeutics Inc (IMPACT) is a developer of therapeutics to treat cancer and other life-threatening diseases. The company provides products such as microtubule inhibitors, PARP-1 inhibitors, and Hedgehog pathway inhibitors for oncology. Its PARP-1 inhibitor is an oral bioavailability; …
  • C.H. Robinson Worldwide Inc (CHRW):企業の財務・戦略的SWOT分析
    C.H. Robinson Worldwide Inc (CHRW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cadence Design Systems Inc (CDNS):企業の財務・戦略的SWOT分析
    Cadence Design Systems Inc (CDNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆